Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice

被引:130
作者
Rieg, Timo [1 ,2 ]
Gerasimova, Maria [2 ]
Murray, Fiona [3 ]
Masuda, Takahiro [1 ,2 ]
Tang, Tong [1 ,2 ]
Rose, Michael [2 ]
Drucker, Daniel J. [4 ]
Vallon, Volker [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[2] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[4] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada
基金
美国国家卫生研究院;
关键词
glucagon-like peptide-1; dipeptidyl peptidase-4; NHE3; cAMP; proximal tubule; GLUCAGON-LIKE PEPTIDE-1; EXCHANGER ISOFORM NHE3; PROXIMAL TUBULE; PHOSPHORYLATION; EXPRESSION; INSULIN; EXENATIDE; IV; SITAGLIPTIN; MECHANISMS;
D O I
10.1152/ajprenal.00259.2012
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rieg T, Gerasimova M, Murray F, Masuda T, Tang T, Rose M, Drucker DJ, Vallon V. Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice. Am J Physiol Renal Physiol 303: F963-F971, 2012. First published July 25, 2012; doi:10.1152/ajprenal.00259.2012.-Activation of the glucagon-like peptide (GLP)-1 receptor (GLP-1R) and inhibition of dipeptidyl peptidase-4 (DPP-4) are new antidiabetic strategies. The GLP-1R and DPP-4 are also expressed in the renal proximal tubular brush border, where they may regulate Na+ reabsorption. Exendin-4 (EX4) is a naturally occurring antidiabetic polypeptide (from the saliva of the lizard Heloderma suspectum) and GLP-1R agonist; however, part of its nonglucoregulatory effects are through GLP-1R-independent mechanisms. DPP-4 cleaves and inactivates GLP-1; thus the natriuretic effect of DPP-4 inhibition may be mediated by the GLP-1R. We report that parenteral application of EX4 in wild-type mice induced a diuresis and natriuresis associated with increases in glomerular filtration rate, fractional urinary fluid and Na+ excretion, and renal membrane expression of the Na+/H+ exchanger NHE3 phosphorylated at S552 and S605, established consensus sites for cAMP-dependent PKA. These effects were absent in mice lacking the GLP-1R and independent of adenylyl cyclase 6. In comparison, parenteral application of the DPP-4 inhibitor alogliptin reduced plasma DPP-4 activity by 95% and induced a diuresis and natriuresis independent of the presence of the GLP-1R or changes in phosphorylated NHE3. The inhibitory effect on renal fluid and Na+ reabsorption of EX4, but not alogliptin, was preserved in diabetic db/db mice and associated with a modest reduction in blood pressure. These results reveal mechanistic differences in how EX4 vs. DPP-4 inhibition induces diuresis and natriuresis under normal states, with preservation of GLP-1R-mediated, but not DPP-4 inhibitor-dependent, natriuretic mechanisms in a mouse model of obese type 2 diabetes.
引用
收藏
页码:F963 / F971
页数:9
相关论文
共 43 条
[1]   Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways [J].
Ban, Kiwon ;
Noyan-Ashraf, M. Hossein ;
Hoefer, Judith ;
Bolz, Steffen-Sebastian ;
Drucker, Daniel J. ;
Husain, Mansoor .
CIRCULATION, 2008, 117 (18) :2340-2350
[2]   Differential expression of adenylyl cyclases in the rat nephron [J].
Bek, MJ ;
Zheng, SP ;
Xu, J ;
Yamaguchi, I ;
Asico, LD ;
Sun, XG ;
Jose, PA .
KIDNEY INTERNATIONAL, 2001, 60 (03) :890-899
[3]   One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress [J].
Bunck, Mathijs C. ;
Corner, Anja ;
Eliasson, Bjorn ;
Heine, Robert J. ;
Shaginian, Rimma M. ;
Wu, Yan ;
Yan, Ping ;
Smith, Ulf ;
Yki-Jarvinen, Hannele ;
Diamant, Michaela ;
Taskinen, Marja-Riitta .
ATHEROSCLEROSIS, 2010, 212 (01) :223-229
[4]   Impaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6) [J].
Chien, Chen-Li ;
Wu, Yu-Shuo ;
Lai, Hsing-Lin ;
Chen, Yen-Hui ;
Jiang, Si-Tse ;
Shih, Chia-Ming ;
Lin, Sui-Shan ;
Chang, Chen ;
Chern, Yijuang .
FEBS LETTERS, 2010, 584 (13) :2883-2890
[5]   Dipeptidyl peptidase IV inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule [J].
Costa Girardi, Adriana Castello ;
Fukuda, Livia Emy ;
Rossoni, Luciana Venturini ;
Malnic, Gerhard ;
Reboucas, Nancy Amaral .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 294 (02) :F414-F422
[6]   Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptino: A randomized, double-mind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes [J].
Covington, Paul ;
Christopher, Ronald ;
Davenport, Michael ;
Fleck, Penny ;
Mekki, Qais A. ;
Wann, Elisabeth R. ;
Karim, Aziz .
CLINICAL THERAPEUTICS, 2008, 30 (03) :499-512
[7]   Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1 [J].
Crajoinas, Renato O. ;
Oricchio, Felipe T. ;
Pessoa, Thaissa D. ;
Pacheco, Bruna P. M. ;
Lessa, Lucilia M. A. ;
Malnic, Gerhard ;
Girardi, Adriana C. C. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 301 (02) :F355-F363
[8]  
DeFronzo RA, 2008, CURR MED RES OPIN, V24, P2943, DOI [10.1185/03007990802418851, 10.1185/03007990802418851 ]
[9]   Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Alogliptin in Patients With Type 2 Diabetes and Inadequate Glycemic Control A randomized, double-blind, placebo-controlled study [J].
DeFronzo, Ralph A. ;
Fleck, Penny R. ;
Wilson, Craig A. ;
Mekki, Qais .
DIABETES CARE, 2008, 31 (12) :2315-2317
[10]   The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes [J].
Drucker, Daniel J. ;
Nauck, Michael A. .
LANCET, 2006, 368 (9548) :1696-1705